Literature DB >> 30097651

Association between vitamin D deficiency and lipid and non-lipid markers of cardiovascular diseases in the middle east region.

Sahar Nakhl1,2, Ghassan Sleilaty3, Salam El Samad4, Youakim Saliba1, Ramez Chahine2, Nassim Farès5.   

Abstract

BACKGROUND: Previous studies have associated vitamin D deficiency with cardiovascular disease (CVD) markers. The underlying mechanism remains elusive. Lipid and non-lipid markers of CVD and their relationship to vitamin D deficiency have not been assessed simultaneously.
OBJECTIVE: To measure the association between vitamin D deficiency and non-lipid markers of CVD after adjustment of lipid markers.
METHODS: This cross-sectional study used the following biological data, which was routinely collected in a general hospital laboratory database between 2011 and 2016: 25OH vitamin D [25(OH)D], creatinine, CKD-EPI eGFR (eGFR), fasting blood glucose (FPG), glycated hemoglobin (HbA1c), uric acid, γ-glutamyl transferase (γGT), C-reactive protein (CRP), total cholesterol, LDL cholesterol, HDL cholesterol, triglycerides, and a surrogate for CVD. Crude odds ratios (ORs) and ORs adjusted for lipid profile, gender and age using separate logistic regression models were derived.
RESULTS: A total of 8658 subjects were included. Half had 25(OH)D < 20 ng/mL. 25(OH)D was associated with increased odds of CRP, eGFR, increased uric acid, γGT, FPG, HbA1c, male gender, CV status, and abnormal lipid markers. After adjustment for lipid markers, age, and gender, vitamin D deficiency was associated with increased odds of CRP, eGFR, γGT, FPG, HbA1c, and the surrogate for CVD.
CONCLUSIONS: In this exploratory analysis, the first of its kind in the MENA region, vitamin D deficiency was associated with abnormal lipid markers, non-lipid markers of CVD, male gender, lower eGFR, and a surrogate variable for CVD. The association between vitamin D deficiency and non-lipid markers of CVD persisted after adjustment for lipid markers, age, and gender.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30097651     DOI: 10.1038/s41430-018-0280-1

Source DB:  PubMed          Journal:  Eur J Clin Nutr        ISSN: 0954-3007            Impact factor:   4.016


  44 in total

1.  Indications on the use of vitamin D and vitamin D metabolites in clinical phenotypes.

Authors:  M L Brandi
Journal:  Clin Cases Miner Bone Metab       Date:  2010-09

2.  Vitamin D and cardiovascular disease will it live up to its hype?

Authors:  Carl J Lavie; John H Lee; Richard V Milani
Journal:  J Am Coll Cardiol       Date:  2011-10-04       Impact factor: 24.094

Review 3.  Vitamin D deficiency.

Authors:  Michael F Holick
Journal:  N Engl J Med       Date:  2007-07-19       Impact factor: 91.245

Review 4.  Blood biomarkers of vitamin D status.

Authors:  Joseph E Zerwekh
Journal:  Am J Clin Nutr       Date:  2008-04       Impact factor: 7.045

Review 5.  Mutations in the vitamin D receptor and hereditary vitamin D-resistant rickets.

Authors:  David Feldman; Peter J Malloy
Journal:  Bonekey Rep       Date:  2014-03-05

Review 6.  The noncalciotropic actions of vitamin D: recent clinical developments.

Authors:  Naim M Maalouf
Journal:  Curr Opin Nephrol Hypertens       Date:  2008-07       Impact factor: 2.894

Review 7.  Vitamin D in preventive medicine: are we ignoring the evidence?

Authors:  Armin Zittermann
Journal:  Br J Nutr       Date:  2003-05       Impact factor: 3.718

Review 8.  Vitamin D deficiency: a worldwide problem with health consequences.

Authors:  Michael F Holick; Tai C Chen
Journal:  Am J Clin Nutr       Date:  2008-04       Impact factor: 7.045

Review 9.  Vitamin D status: measurement, interpretation, and clinical application.

Authors:  Michael F Holick
Journal:  Ann Epidemiol       Date:  2008-03-10       Impact factor: 3.797

Review 10.  Vitamin D and multiple health outcomes: umbrella review of systematic reviews and meta-analyses of observational studies and randomised trials.

Authors:  Evropi Theodoratou; Ioanna Tzoulaki; Lina Zgaga; John P A Ioannidis
Journal:  BMJ       Date:  2014-04-01
View more
  5 in total

1.  Anti-Inflammatory Effects of a Period of Aerobic Training and Vitamin D Supplementation in Postmenopausal Women with Metabolic Syndrome.

Authors:  Parivash Najafi Nazarabadi; Zaher Etemad; Rastegar Hoseini; Fatah Moradi
Journal:  Int J Prev Med       Date:  2022-04-08

2.  FokI vitamin D receptor gene polymorphism and serum 25-hydroxyvitamin D in patients with cardiovascular risk.

Authors:  Sahar Nakhl; Ghassan Sleilaty; Eliane Chouery; Nabiha Salem; Ramez Chahine; Nassim Farès
Journal:  Arch Med Sci Atheroscler Dis       Date:  2019-12-31

3.  Adequate 25-hydroxyvitamin D levels are inversely associated with various cardiometabolic risk factors in Chinese children, especially obese children.

Authors:  Pei Xiao; Hongbo Dong; Haibo Li; Yinkun Yan; Hong Cheng; Junting Liu; Xiaoyuan Zhao; Dongqing Hou; Jie Mi
Journal:  BMJ Open Diabetes Res Care       Date:  2020-02

4.  Serum 25-hydroxyvitamin D might be negatively associated with hyperuricemia in U.S. adults: an analysis of the National Health and Nutrition Examination Survey 2007-2014.

Authors:  Y Han; K Han; Y Zhang; X Zeng
Journal:  J Endocrinol Invest       Date:  2021-08-26       Impact factor: 4.256

5.  The association of coffee consumption rate with serum 25-hydroxyvitamin D, non-HDL levels, and TC/HDL ratio in females with vitamin D deficiency.

Authors:  Maha Habash; Sami Al-Shakhshir; Mohammad Abusamak; Mohammad Yasin Mohammad; Mahmoud AbuSamak
Journal:  Womens Health (Lond)       Date:  2022 Jan-Dec
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.